4-38798089-T-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_003263.4(TLR1):​c.743A>G​(p.Asn248Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.289 in 1,613,238 control chromosomes in the GnomAD database, including 90,036 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign,risk factor (no stars).

Frequency

Genomes: 𝑓 0.44 ( 19255 hom., cov: 32)
Exomes 𝑓: 0.27 ( 70781 hom. )

Consequence

TLR1
NM_003263.4 missense

Scores

1
16

Clinical Significance

Benign; risk factor no assertion criteria provided B:1O:1

Conservation

PhyloP100: -0.964

Publications

306 publications found
Variant links:
Genes affected
TLR1 (HGNC:11847): (toll like receptor 1) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is ubiquitously expressed, and at higher levels than other TLR genes. Different length transcripts presumably resulting from use of alternative polyadenylation site, and/or from alternative splicing, have been noted for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.6334178E-6).
BP6
Variant 4-38798089-T-C is Benign according to our data. Variant chr4-38798089-T-C is described in ClinVar as Benign|risk_factor. ClinVar VariationId is 8361.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.784 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003263.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR1
NM_003263.4
MANE Select
c.743A>Gp.Asn248Ser
missense
Exon 4 of 4NP_003254.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR1
ENST00000308979.7
TSL:1 MANE Select
c.743A>Gp.Asn248Ser
missense
Exon 4 of 4ENSP00000354932.2
TLR1
ENST00000502213.7
TSL:1
c.743A>Gp.Asn248Ser
missense
Exon 4 of 4ENSP00000421259.1
TLR1
ENST00000505744.6
TSL:3
n.235+2768A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.436
AC:
66260
AN:
152006
Hom.:
19203
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.791
Gnomad AMI
AF:
0.318
Gnomad AMR
AF:
0.503
Gnomad ASJ
AF:
0.418
Gnomad EAS
AF:
0.597
Gnomad SAS
AF:
0.490
Gnomad FIN
AF:
0.114
Gnomad MID
AF:
0.566
Gnomad NFE
AF:
0.239
Gnomad OTH
AF:
0.483
GnomAD2 exomes
AF:
0.381
AC:
95308
AN:
250080
AF XY:
0.374
show subpopulations
Gnomad AFR exome
AF:
0.801
Gnomad AMR exome
AF:
0.517
Gnomad ASJ exome
AF:
0.414
Gnomad EAS exome
AF:
0.595
Gnomad FIN exome
AF:
0.120
Gnomad NFE exome
AF:
0.266
Gnomad OTH exome
AF:
0.368
GnomAD4 exome
AF:
0.273
AC:
399521
AN:
1461114
Hom.:
70781
Cov.:
36
AF XY:
0.279
AC XY:
202717
AN XY:
726712
show subpopulations
African (AFR)
AF:
0.808
AC:
27057
AN:
33472
American (AMR)
AF:
0.513
AC:
22893
AN:
44662
Ashkenazi Jewish (ASJ)
AF:
0.412
AC:
10764
AN:
26128
East Asian (EAS)
AF:
0.634
AC:
25154
AN:
39688
South Asian (SAS)
AF:
0.481
AC:
41478
AN:
86210
European-Finnish (FIN)
AF:
0.124
AC:
6623
AN:
53380
Middle Eastern (MID)
AF:
0.532
AC:
3067
AN:
5768
European-Non Finnish (NFE)
AF:
0.218
AC:
242642
AN:
1111434
Other (OTH)
AF:
0.329
AC:
19843
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
14517
29033
43550
58066
72583
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8614
17228
25842
34456
43070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.436
AC:
66372
AN:
152124
Hom.:
19255
Cov.:
32
AF XY:
0.435
AC XY:
32398
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.791
AC:
32847
AN:
41502
American (AMR)
AF:
0.503
AC:
7683
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.418
AC:
1448
AN:
3466
East Asian (EAS)
AF:
0.597
AC:
3086
AN:
5168
South Asian (SAS)
AF:
0.490
AC:
2364
AN:
4824
European-Finnish (FIN)
AF:
0.114
AC:
1212
AN:
10608
Middle Eastern (MID)
AF:
0.571
AC:
168
AN:
294
European-Non Finnish (NFE)
AF:
0.239
AC:
16245
AN:
67960
Other (OTH)
AF:
0.486
AC:
1029
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1448
2897
4345
5794
7242
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
558
1116
1674
2232
2790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.331
Hom.:
41573
Bravo
AF:
0.480
TwinsUK
AF:
0.226
AC:
837
ALSPAC
AF:
0.248
AC:
954
ESP6500AA
AF:
0.777
AC:
3424
ESP6500EA
AF:
0.249
AC:
2141
ExAC
AF:
0.393
AC:
47671
Asia WGS
AF:
0.564
AC:
1960
AN:
3478

ClinVar

Significance: Benign; risk factor
Submissions summary: Benign:1Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

TLR1-related disorder Benign:1
Oct 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Leprosy, susceptibility to, 5 Other:1
Jun 15, 2009
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.80
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.27
DANN
Benign
0.43
DEOGEN2
Benign
0.24
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.050
N
LIST_S2
Benign
0.060
T
MetaRNN
Benign
0.0000026
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L
PhyloP100
-0.96
PrimateAI
Benign
0.23
T
PROVEAN
Uncertain
-2.5
D
REVEL
Benign
0.028
Sift
Benign
0.17
T
Sift4G
Benign
0.25
T
Polyphen
0.0010
B
Vest4
0.016
MPC
0.053
ClinPred
0.0096
T
GERP RS
-3.2
Varity_R
0.11
gMVP
0.14
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4833095; hg19: chr4-38799710; COSMIC: COSV58303357; COSMIC: COSV58303357; API